Skip to main content
. 2006 Aug 16;62(6):699–709. doi: 10.1111/j.1365-2125.2006.02741.x

Figure 4.

Figure 4

Observed (black) and predicted distribution of the total sustained virological response (SVR) and incidence of anaemia in patients with hepatitis C virus (HCV) genotype 1 receiving 48 weeks’ treatment with standard-dose (1000 or 1200 mg according to body weight) ribavirin